Effects of ketamine on precipitated morphine withdrawal symptoms in rats and its possible mechanism

盛国庆,张晋蓉,邢淑华,蒲小平,李长龄,戴体俊
2002-01-01
Abstract:AIM: To elucidate the effects of ketamine on naloxone-precipitated morphine withdrawal symptoms in rats and its possible mechanism. METHODS: Naloxone-precipitated morphine withdrawal symptoms were observed in morphine-dependent rats. Various doses of ketamine or normal saline were administrated ip to rats 2 min before the test. Nitric oxide synthase(NOS) activity and nitric oxide (NO) output were assessed with spectrophotometric analysis, concentration of cyclic guanosine monophosphate (cGMP) was measured with radioimmunoassay. RESULTS: Ketamine (5, 10, 20 mg·kg -1, ip) can significantly attenuate the counted withdrawal behaviors (numbers of jumps, wet dog shakes, rearing as well as writhing movements); various doses of ketamine effectively inhibited autonomic hyperactivity such as salivation, tearing, diarrhea (P < 0.05); weight loss across the abstinence session was attenuated by ketamine at the doses of 10, 20 mg·kg -1 (P < 0.05). Levels of NOS activity, NO output as well as cGMP content in cerebellum, prefrontal cortex during the period of morphine withdrawal were increased significantly compared with saline group (P < 0.05), while pretreatment of ketamine could inhibit the enhanced NOS activity, NO output as well as concentration of cGMP in morphine abstinence session (P < 0.05). CONCLUSION: Withdrawal symptoms in morphine dependent rats can be attenuated by pretreatment of ketamine, the mechanism may be related to the suppression of up-regulation of NMDA-NO-cGMP signaling pathway.
What problem does this paper attempt to address?